Showing results (41-50 of 58) with videos related to
Sort By:
Pageof 6
International Journal of Systematic and Evolutionary Microbiology|March 6, 2019
Genome-based classification of two halotolerant extreme acidophiles, Acidihalobacter prosperus V6 (=DSM 14174 =JCM 32253) and 'Acidihalobacter ferrooxidans' V8 (=DSM 14175 =JCM 32254) as two new species, Acidihalobacter aeolianus sp. nov. and Acidihalobacter ferrooxydans sp. nov., respectivelyHimel N Khaleque, Carolina González, Anna H Kaksonen, et al.Journal of Biotechnology|October 8, 2017
Complete genome sequence of Acidihalobacter prosperus strain F5, an extremely acidophilic, iron- and sulfur-oxidizing halophile with potential industrial applicability in saline water bioleaching of chalcopyriteHimel N Khaleque, Melissa K Corbett, Joshua P Ramsay, et al.Genome Announcements|January 21, 2017
Draft Genome Sequence of the Acidophilic, Halotolerant, and Iron/Sulfur-Oxidizing Acidihalobacter prosperus DSM 14174 (Strain V6)Himel Nahreen Khaleque, Joshua P Ramsay, Riley J T Murphy, et al.Genome Announcements|May 27, 2017
Draft Genome Sequence of Acidihalobacter ferrooxidans DSM 14175 (Strain V8), a New Iron- and Sulfur-Oxidizing, Halotolerant, Acidophilic SpeciesHimel N Khaleque, Joshua P Ramsay, Riley J T Murphy, et al.Clinical Radiology|March 7, 2009
Prospective assessment of MRI for imaging retroperitoneal metastases from testicular germ cell tumoursS A Sohaib, D M Koh, Y Barbachano, et al.SLAS Discovery : Advancing Life Sciences R & D|March 16, 2017
Microfluidic Mobility Shift Assay for Real-Time Analysis of Peptide N-PalmitoylationThomas Lanyon-Hogg, Neki V Patel, Markus Ritzefeld, et al.The EMBO Journal|June 24, 2006
Trans-activation of the DNA-damage signalling protein kinase Chk2 by T-loop exchangeAntony W Oliver, Angela Paul, Katherine J Boxall, et al.British Journal of Cancer|October 20, 2005
Effects of platinum/taxane based chemotherapy on acute perfusion in human pelvic tumours measured by dynamic MRIK J Lankester, N J Taylor, J J Stirling, et al.Cancer Research|January 18, 2011
CCT241533 is a potent and selective inhibitor of CHK2 that potentiates the cytotoxicity of PARP inhibitorsVictoria E Anderson, Michael I Walton, Paul D Eve, et al.British Journal of Cancer|April 15, 2010
A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancerG J Rustin, G Shreeves, P D Nathan, et al.Pageof 6